Rokit Healthcare Presents Two-Year Follow-Up Results of Skin Cancer Regeneration at EWMA

Rokit Healthcare announced on May 6 that it will present clinical data on regenerative treatments for skin cancer at "EWMA 2026," the annual conference of the European Wound Management Association. The conference is being held in Bremen, Germany, from May 6 to May 8. The company will share results in a session on May 7, disclosing outcomes from AI bioprinting-based autologous fat tissue regeneration following skin cancer tissue excision, along with long-term follow-up data from one to two years.

Photo of Rokit Healthcare's EWMA 2026 booth. Rokit Healthcare

원본보기 아이콘

According to Rokit Healthcare, no recurrence was observed in patients treated with this technology during a follow-up period of up to two years. Functional recovery of the excision site, aesthetic improvement, restoration of sensation, and minimization of scarring were also observed. Conventional treatments, which focus on skin grafting or suturing after tumor removal, can lead to scarring and functional impairment.

Europe is a region with a high incidence of skin cancer, and the non-melanoma skin cancer treatment market is estimated to reach approximately $890 million (about 1.3065 trillion won) by 2025. The company stated that its regenerative approach using patients' own tissues can reduce costs and alleviate the treatment burden.

During the conference, Rokit Healthcare plans to showcase its AI regeneration platform and demonstrate the entire process from lesion scanning to the production of regenerative patches. The company is also working to establish partnerships by negotiating with leading hospitals and medical device distributors in Europe, including Germany and France. It aims to sign contracts with three partners in Europe and the Middle East within the first half of the year.

The company has expanded its regenerative technology, previously used for diabetic foot treatment, to skin cancer reconstruction and plans to broaden its application to organ regeneration, including cartilage and kidneys, in the future.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.